Geraldine Pannu
Geraldine Pannu's purchase track record
Geraldine Pannu has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 3/31/2026 | PCSA | $5K | -24.0% | -30.3% | +17.5% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
RBB Bancorp to Report Third Quarter 2026 Financial Results. RBB Bancorp has announced it will release its third-quarter 2026 financial results. This upcoming report is the primary focus for the stock, as it will provide updated insights into the bank's performance. Investors will likely watch these figures to see how the company is managing its operations and earnings.
Transaction History
| PCSA | ▲ Buy | Option Exercise | 203 | — | 6/26/2026 | View on chart |
| RBB | ▲ Buy | Option Exercise | 700 | $0 | 5/21/2026 | View on chart |
| RBB | ▲ Buy | Option Exercise | 1,846 | $0 | 5/21/2026 | View on chart |
| PCSA | ▲ Buy | Open Market | 2,072 | $5K | 3/31/2026 | View on chart |
| RBB | ▲ Buy | Option Exercise | 2,821 | $0 | 5/21/2025 | View on chart |
| RBB | ▲ Buy | Option Exercise | 700 | $0 | 5/15/2025 | View on chart |
| RBB | ▲ Buy | Option Exercise | 800 | $0 | 5/16/2024 | View on chart |
| RBB | ▲ Buy | Option Exercise | 600 | $0 | 1/18/2024 | View on chart |
| PCSA | ▲ Buy | Grant | 4,500 | $945 | 10/10/2023 | View on chart |
| PCSA | ▲ Buy | Option Exercise | 23,636 | — | 6/27/2023 | View on chart |
| RBB | ▲ Buy | Option Exercise | 800 | $0 | 1/18/2023 | View on chart |
| PCSA | ▲ Buy | Option Exercise | 18,208 | — | 12/31/2022 | View on chart |
| PCSA | ▲ Buy | Option Exercise | 1,169 | — | 8/5/2022 | View on chart |
| PCSA | ▲ Buy | Grant | 4,393 | — | 3/31/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Processa Files Prospectus for 306.5M Share Offering
Processa Pharmaceuticals filed a prospectus for an offering of 306.574 million common shares on behalf of selling shareholders. This large-scale secondary offering adds significant supply to the market, which may pressure the stock price. The company is currently trading near the lower end of its 52-week range, with technical indicators showing weakness.
Processa Files Prospectus for 306.5M Share Offering. Processa Pharmaceuticals filed a prospectus for an offering of 306.574 million common shares on behalf of selling shareholders. This large-scale secondary offering adds significant supply to the market, which may pressure the stock price. The company is currently trading near the lower end of its 52-week range, with technical indicators showing weakness.